Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs.

Clinical xenotransplantations have been hampered by human preformed antibody-mediated damage of the xenografts. To overcome biological incompatibility between pigs and humans, one strategy is to remove the major antigens [Gal, Neu5Gc, and Sd(a)] present on pig cells and tissues. Triple gene (GGTA1, CMAH, and β 4GalNT2) knockout (TKO) pigs were produced in our laboratory by CRISPR-Cas9 targeting. To investigate the antigenicity reduction in the TKO pigs, the expression levels of these three xenoantigens in the cornea, heart, liver, spleen, lung, kidney, and pancreas tissues were examined. The level of human IgG/IgM binding to those tissues was also investigated, with wildtype pig tissues as control. The results showed that αGal, Neu5Gc, and Sd(a) were markedly positive in all the examined tissues in wildtype pigs but barely detected in TKO pigs. Compared to wildtype pigs, the liver, spleen, and pancreas of TKO pigs showed comparable levels of human IgG and IgM binding, whereas corneas, heart, lung, and kidney of TKO pigs exhibited significantly reduced human IgG and IgM binding. These results indicate that the antigenicity of TKO pig is significantly reduced and the remaining xenoantigens on porcine tissues can be eliminated via a gene targeting approach.

[1]  Rongfeng Li,et al.  Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH. , 2018, Acta biomaterialia.

[2]  C. McGregor,et al.  Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate? , 2017, Journal of immunology research.

[3]  D. Cooper,et al.  Low anti‐pig antibody levels are key to the success of solid organ xenotransplantation: But is this sufficient? , 2017, Xenotransplantation.

[4]  D. Cooper,et al.  Xenotransplantation: past, present, and future , 2017, Current opinion in organ transplantation.

[5]  R. Pierson,et al.  Regulation of Clinical Xenotransplantation-Time for a Reappraisal. , 2017, Transplantation.

[6]  R. Colvin,et al.  Prolonged Survival Following Pig‐to‐Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  S. Matsumoto,et al.  Level of acceptance of islet cell and kidney xenotransplants by personnel of hospitals with and without experience in clinical xenotransplantation , 2017, Xenotransplantation.

[8]  M. Tector,et al.  Eliminating Xenoantigen Expression on Swine RBC , 2017, Transplantation.

[9]  E. Wolf,et al.  Progress in Clinical Encapsulated Islet Xenotransplantation. , 2016, Transplantation.

[10]  K. Kyriakopoulou,et al.  Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves , 2016, Acta biomaterialia.

[11]  R. Pierson,et al.  Lung xenotransplantation: a review , 2016, Current opinion in organ transplantation.

[12]  R. Bottino,et al.  Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs , 2016, Xenotransplantation.

[13]  D. Ayares,et al.  The role of genetically engineered pigs in xenotransplantation research , 2016, The Journal of pathology.

[14]  H. Niemann,et al.  Efficient generation of a triple knockout (GGTA1/CMAH/ASGR1) of xenorelevant genes in pig fibroblasts , 2015 .

[15]  Takaaki Kobayashi,et al.  Current status of pig kidney xenotransplantation. , 2015, International journal of surgery.

[16]  M. Tector,et al.  Evaluation of human and non‐human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes , 2015, Xenotransplantation.

[17]  M. Tector,et al.  Pre‐transplant antibody screening and anti‐CD154 costimulation blockade promote long‐term xenograft survival in a pig‐to‐primate kidney transplant model , 2015, Xenotransplantation.

[18]  T. Yokoo,et al.  Kidney regeneration using developing xenoembryo , 2015, Current opinion in organ transplantation.

[19]  R. Słomski,et al.  Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-α-1,3-galactose (α-Gal) antigen derived tissue and tissue engineering technique , 2015, Journal of Materials Science: Materials in Medicine.

[20]  C. McGregor,et al.  Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen , 2014, Xenotransplantation.

[21]  Alejandro E. Brito,et al.  N‐linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens , 2013, Xenotransplantation.

[22]  H. Tazelaar,et al.  Human CD55 Expression Blocks Hyperacute Rejection and Restricts Complement Activation in Gal Knockout Cardiac Xenografts , 2012, Transplantation.

[23]  Ashutosh Kumar Singh,et al.  B‐Cell Depletion Extends the Survival of GTKO.hCD46Tg Pig Heart Xenografts in Baboons for up to 8 Months , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  Y. Mizuguchi,et al.  Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs. , 2011, Investigative ophthalmology & visual science.

[25]  T. Starzl,et al.  Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys , 2005, Nature Medicine.

[26]  M. Araie,et al.  Antigenicity of porcine cornea as xenograft , 2003, Current eye research.

[27]  Yifan Dai,et al.  Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs , 2002, Nature Biotechnology.

[28]  B. N. Day,et al.  Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning , 2002, Science.

[29]  Yifan Dai,et al.  Initial study of α1,3‐galactosyltransferase gene‐knockout/CD46 pig full‐thickness corneal xenografts in rhesus monkeys , 2017, Xenotransplantation.

[30]  Yifan Dai,et al.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. , 2002, Nature biotechnology.